SMC Rejects Pregabalin for Nerve Pain

September 13, 2005 on 5:04 pm | In Prescribing Extra - Drugs | Print Print |

The Scottish Medicines Consortium has completed an appraisal following a re-submission for Lyrica (Pregabalin).

They have concluded that based on current data clinical and cost effectiveness has not been demonstrated for patients who fail to respond to current treatments.

Action: Continue using conventional therapies for the treatment of pain caused by peripheral damage to nerves. Do not use Pregabalin when other treatments fail.

Copyright ©2005 Prescribing Advice for GPs

No Comments yet »

RSS feed for comments on this post. TrackBack URI

Leave a comment

XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS Feed for New Entries.
Akismet has protected Prescribing Advice for GPs from 3,097 spam comments.